Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) Short Interest Update

Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) saw a large drop in short interest in May. As of May 15th, there was short interest totaling 36,079 shares, a drop of 88.1% from the April 30th total of 303,052 shares. Based on an average daily volume of 676,732 shares, the short-interest ratio is presently 0.1 days. Currently, 0.9% of the shares of the stock are short sold.

Defiance Daily Target 2X Long LLY ETF Price Performance

LLYX stock traded down $0.95 during trading on Friday, reaching $24.02. 486,504 shares of the company were exchanged, compared to its average volume of 466,942. The company has a 50-day moving average of $18.45 and a two-hundred day moving average of $21.91. Defiance Daily Target 2X Long LLY ETF has a twelve month low of $9.60 and a twelve month high of $28.44.

Institutional Investors Weigh In On Defiance Daily Target 2X Long LLY ETF

A hedge fund recently bought a new stake in Defiance Daily Target 2X Long LLY ETF stock. Jump Financial LLC bought a new stake in Defiance Daily Target 2X Long LLY ETF (NYSEARCA:LLYX) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 9,186 shares of the company’s stock, valued at approximately $234,000. Jump Financial LLC owned about 0.54% of Defiance Daily Target 2X Long LLY ETF at the end of the most recent quarter.

About Defiance Daily Target 2X Long LLY ETF

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.